-+ 0.00%
-+ 0.00%
-+ 0.00%

JP Morgan Reinstates Overweight on MBX Biosciences, Announces $88 Price Target

Benzinga·08/21/2026 19:01:40
语音播报
JP Morgan analyst Jessica Fye reinstates MBX Biosciences (NASDAQ:MBX) with a Overweight and announces $88 price target.